Aster Capital Management’s First Tracks Biotherapeutics TRAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.9K Buy
+590
New +$23K 0.01% 696

Other funds holding TRAX

Aster Capital Management's TRAX Position: Q3 2026 in Review

Aster Capital Management opened a new position in First Tracks Biotherapeutics (TRAX) in Q3 2026: 590 shares worth $20.9K. The stake represents 0.01% of the portfolio and ranks #696 among its holdings.

182 funds tracked by Wall St. Rank hold TRAX as of Q3 2026.

  • Aster Capital Management held 590 shares of First Tracks Biotherapeutics worth $20.9K as of Q3 2026.
  • First Tracks Biotherapeutics was a new Aster Capital Management position in Q3 2026.
  • First Tracks Biotherapeutics made up 0.01% of Aster Capital Management's portfolio in Q3 2026, its #696 holding.
  • 182 funds tracked by Wall St. Rank held First Tracks Biotherapeutics as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.